Apretude (long-acting cabotegravir or CAB-LA) is a prescription long-acting injectable medication used for HIV pre-exposure prophylaxis (PrEP). It's administered by a healthcare provider as an intramuscular injection into the gluteal (buttock) muscle every two months. It's Health Canada approved as a PrEP option.